Insiders / Nagendran Sukumar / Activity
Activity — Nagendran Sukumar
9 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Sell | TSHA Taysha Gene Therapies, Inc. Common Stock | $942.0K | -200K -16.58% | 1,006,439 0.31% of shares | medium |
| Jan 23, 2026 | Sell | TSHA Taysha Gene Therapies, Inc. Common Stock | $423.4K | -89K -6.22% | 1,344,307 0.41% of shares | medium |
| Jan 12, 2026 | Exercise | TSHA Taysha Gene Therapies, Inc. Common Stock | $151.6K | +89K +7.93% | 1,206,439 0.37% of shares | low |
| Jan 26, 2026 | Sell | TSHA Taysha Gene Therapies, Inc. Common Stock | $124.1K | -27K -2.00% | 1,317,389 0.40% of shares | medium |
| Jan 12, 2026 | Exercise | TSHA Taysha Gene Therapies, Inc. Common Stock | $77.8K | +111K +11.06% | 1,117,763 0.34% of shares | low |
| Jan 12, 2026 | Grant | TSHA Taysha Gene Therapies, Inc. Common Stock | $0 | +427K +42.43% | 1,433,439 0.44% of shares | low |
| Jan 12, 2026 | Grant | TSHA Taysha Gene Therapies, Inc. Employee Stock Option (right to buy) | — | +274K | 274,000 0.08% of shares | low |
| Jan 12, 2026 | Exercise | TSHA Taysha Gene Therapies, Inc. Employee Stock Option (right to buy) | — | -89K -15.73% | 474,941 0.15% of shares | low |
| Jan 12, 2026 | Exercise | TSHA Taysha Gene Therapies, Inc. Employee Stock Option (right to buy) | — | -111K -49.99% | 111,359 0.03% of shares | low |